Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: a case report and literature review Y Samhouri, S Ursu, N Dutton, V Tanvi, S Fazal Journal of Oncology Pharmacy Practice 27 (4), 990-995, 2021 | 21 | 2021 |
Intrathecal chemotherapy as a potential treatment for steroid-refractory immune effector cell-associated neurotoxicity syndrome P Asawa, U Vusqa, C Khan, Y Samhouri, S Fazal Anticancer Research 42 (8), 3853-3856, 2022 | 11 | 2022 |
Utilization of 4T score to determine the pretest probability of heparin-induced thrombocytopenia in a community hospital in upstate New York Y Samhouri, M Telfah, R Kouides, T Woodlock Journal of Community Hospital Internal Medicine Perspectives 6 (4), 32522, 2016 | 11 | 2016 |
Intensity of cancer care near the end of life at a tertiary care cancer center in Jordan H Abdel-Razeq, O Shamieh, M Abu-Nasser, M Nassar, Y Samhouri, ... Journal of pain and symptom management 57 (6), 1106-1113, 2019 | 7 | 2019 |
The trend of combined modality treatment and its outcomes in elderly patients with primary CNS lymphoma: a 12-year population-based analysis using propensity score Y Samhouri, MKM Ali, C Khan, R Wegner, ST Lee, J Lister Anticancer Research 42 (4), 1867-1877, 2022 | 5 | 2022 |
Rare oral presentation of a mycophenolate mofetil-related other iatrogenic immunodeficiency-associated lymphoproliferative disorder (MMF-OIA-LPD) lesion: a case report and … A Taliaferro, Y Samhouri, J Rice, CM Khan, JE Cillo Journal of Oral and Maxillofacial Surgery 79 (2), 398-403, 2021 | 5 | 2021 |
Impact of education and electronic decision support tool on the practice of heparin-induced thrombocytopenia testing: an experience of a teaching community hospital A Arshad, L Alnimer, Y Samhouri, R Kouides, T Woodlock Thrombosis Research 169, 73-75, 2018 | 5 | 2018 |
Venetoclax-induced vitiligo in a patient with chronic lymphocytic leukemia M Abdeen, UT Vusqa, P Asawa, K Felton, D Rinchuse, C Khan, ... Anti-Cancer Drugs 33 (10), 1167-1170, 2022 | 4 | 2022 |
Polyserositis as a unique presentation of isolated myeloid sarcoma: a case report P Asawa, U Vusqa, K Vashistha, MTU Din, R Karna, F Chen, N Dutton, ... Anticancer research 42 (7), 3595-3599, 2022 | 4 | 2022 |
Management of congenital dysfibrinogenemia in pregnancy: A challenging patient case M Langer, M Manire, M Clarkson, Y Samhouri, D Shah, R Bhagavatula Research and Practice in Thrombosis and Haemostasis 5 (8), e12619, 2021 | 4 | 2021 |
Haemophagocytic lymphohistiocytosis that spontaneously resolved: a case of EBV Z Chahine, T Jayakrishnan, Y Samhouri, S Fazal BMJ Case Reports CP 13 (11), e235544, 2020 | 4 | 2020 |
Outcomes of treatment for HIV-Infected Lymphoma patients: a National Cancer Database (NCDB) analysis TT Jayakrishnan, V Bakalov, Y Samhouri, RE Wegner, S Sadashiv Clinical Lymphoma Myeloma and Leukemia 20 (11), e864-e870, 2020 | 4 | 2020 |
747 Phase 1 trial of LYL845, an autologous tumor-infiltrating lymphocyte (TIL) therapy enhanced with epigenetic reprogramming, for the treatment of advanced solid tumors Y Samhouri, JD Beane, S Weiss, JR Hecht, J Hyngstrom, BA Hanks, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | 3 | 2023 |
A meningioma mimic and distinct subtype of primary central nervous system lymphoma: primary dural lymphoma S Sreenivasan, R Solanki, P Kancharla, C Khan, Y Samhouri Journal of Hematology 12 (2), 87, 2023 | 3 | 2023 |
Predictors and long-term outcomes for diffuse large B-cell lymphoma (DLBCL) patients undergoing surgery prior to systemic therapy: a nationwide analysis U Vusqa, TT Jayakrishnan, V Bakalov, Z Chahine, R Wegner, C Khan, ... Cureus 14 (4), 2022 | 3 | 2022 |
A rare case of small bowel extramedullary plasmacytomas presenting with intestinal obstruction L Alnimer, A Zakaria, B Alshare, Y Samhouri, M Raphael Cureus 13 (6), 2021 | 3 | 2021 |
Spontaneous tumour lysis syndrome in multiple myeloma with loss of 17p13. 1, t (4; 14) and monosomy 13 B Tbakhi, S Hanna, Y Samhouri, D Lingutla BMJ Case Reports CP 14 (2), e234122, 2021 | 3 | 2021 |
Efficacy of venetoclax based regimens in relapsed refractory multiple myeloma: a systematic review and meta-analysis L Hashim, MS Faisal, Z Ahmed, II Selene, M Shahzad, SM Abdullah, ... Blood 136, 39-40, 2020 | 3 | 2020 |
778 TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy combined with pembrolizumab (pembro) vs pembro alone in treatment-naïve … DJ Olson, J Larkin, Y Hong, S Thomas, J Martin-Liberal, AJS Furness, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | 2 | 2023 |
Patterns of treatment and their outcomes in primary breast lymphoma; a comprehensive population-based analysis MK Mustafa Ali, Y Samhouri, JY Law, C Khan, R Wegner, ST Lee, J Lister Breast Cancer 29 (6), 1022-1031, 2022 | 2 | 2022 |